DEFECTIVE MUTANT NON-RETROVIRAL VIRUS (E.G. HSV) AS VACCINE - Patent 0689603

(19)

(11)

EP 0 689 603 A1

(12)

(43)	Date of publication:
	03.01.1996 Bulletin 1996/01

(21)	Application number: 94909990.0

(22)	Date of filing: 21.03.1994

(51)

International Patent Classification (IPC):

C12N 15/ 09^{( . )}
A61P 31/ 12^{( . )}
C12N 7/ 04^{( . )}
A61K 38/ 00^{( . )}

A61K 39/ 245^{( . )}
C07K 14/ 035^{( . )}
C12N 15/ 869^{( . )}
A61K 39/ 00^{( . )}

(86)	International application number:
	PCT/GB1994/000572

(87)	International publication number:
	WO 1994/021807 (29.09.1994 Gazette 1994/22)

(84)	Designated Contracting States:
	AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

(30)

Priority:

19.03.1993 GB 19930005710
06.12.1993 GB 19930024964

(71)	Applicant: CANTAB PHARMACEUTICALS RESEARCH LIMITED
	Cambridge CB4 4GN (GB)

(72)	Inventors:
	INGLIS, Stephen Charles 2 Rhugarve Gardens Cambridge CB1 6LX (GB) BOURSNELL, Michael Edward Griffith Cambridge CB1 4NY (GB) MINSON, Anthony Charles 113 Cambridge Road Cambridge CB2 5JJ (GB)

(74)	Representative: O'Brien, Caroline Jane
	MEWBURN ELLIS York House 23 Kingsway London WC2B 6HP London WC2B 6HP (GB)

(54)	DEFECTIVE MUTANT NON-RETROVIRAL VIRUS (E.G. HSV) AS VACCINE